What is BPC-157?
BPC-157 stands for Body Protection Compound-157. It's a pentadecapeptide, which is a fancy way of saying it's a chain of 15 amino acids. Researchers first isolated it from human gastric juice in the early 1990s, and it's been a subject of serious scientific interest ever since.
What makes BPC-157 unusual is that it's a fragment of a naturally occurring protein in the human stomach. It doesn't come from a lab first and get tested later. It was found in the body first, then studied to understand what it does.
Over 150 peer-reviewed papers have been published on BPC-157 to date, making it one of the most-studied peptides in the research chemical space.
How was BPC-157 discovered?
In 1991, a team of Croatian researchers led by Dr. Predrag Sikiric was studying gastric juice, the fluid your stomach produces to break down food. They isolated a partial sequence of a larger protein and noticed something interesting: this fragment showed remarkable stability even in highly acidic conditions.
Most peptides degrade quickly in stomach acid. BPC-157 didn't. That caught their attention, and they started running experiments.
The early findings were striking enough that the team devoted the next three decades to studying the compound. The University of Zagreb remains the primary research institution for BPC-157 literature today.
What have researchers observed in studies?
The published literature on BPC-157 spans several areas of investigation. Here's what the research has explored:
Tissue repair models. Multiple preclinical studies have observed accelerated healing in tendon, ligament, and muscle tissue models treated with BPC-157. A 2003 study by Staresinic et al. documented improved tensile strength in transected rat Achilles tendons.
Gut integrity. Given its origin in gastric juice, BPC-157 has been extensively studied in gastrointestinal models. Researchers have observed cytoprotective activity in various inflammatory bowel models.
The nitric oxide (NO) system. BPC-157 has been observed to interact with the nitric oxide system, which plays a role in blood vessel formation and tissue repair signaling. This is one of the proposed mechanisms for its activity in preclinical models.
Angiogenesis. Several studies have noted increased formation of new blood vessels in tissue samples treated with BPC-157, which researchers believe may contribute to the repair activity observed in other models.
What is the molecular structure?
BPC-157 is a pentadecapeptide with the following amino acid sequence:
Gly-Glu-Pro-Pro-Pro-Gly-Lys-Pro-Ala-Asp-Asp-Ala-Gly-Leu-Val
Its molecular weight is 1419.53 Da. The compound is typically supplied in lyophilized (freeze-dried) form for research applications. It demonstrates unusual stability for a peptide of its size, maintaining structural integrity in conditions that would degrade most comparable compounds.
BPC-157What should researchers know before working with BPC-157?
Storage. Lyophilized BPC-157 should be stored at -20°C for long-term stability. Once reconstituted, refrigerate at 2-8°C and use within a reasonable timeframe.
Purity verification. Always request a Certificate of Analysis (CoA) from your supplier. Third-party HPLC testing should confirm purity of 98% or higher. Mass spectrometry should confirm the correct molecular weight.
Published concentrations. The preclinical literature reports a range of concentrations depending on the model and route of administration. Researchers should consult the specific studies relevant to their area of investigation.
The bottom line
BPC-157 is one of the most thoroughly documented peptides in the research chemical catalog. With over 150 published studies spanning three decades, the body of preclinical literature is substantial. The compound's origin in human gastric juice, its unusual stability, and the breadth of research interest make it a compelling subject for continued investigation.
All BPC-157 sold by Kern Peptides comes with a batch-specific Certificate of Analysis and is intended strictly for research use.
Frequently Asked Questions
What does BPC-157 stand for?
BPC-157 stands for Body Protection Compound-157. It's a synthetic version of a pentadecapeptide originally isolated from human gastric juice by Croatian researchers in the early 1990s.
How many studies have been published on BPC-157?
Over 150 peer-reviewed papers have been published on BPC-157, primarily from the University of Zagreb. The research spans tissue repair, gastrointestinal models, and nitric oxide system interactions.
Is BPC-157 FDA approved?
No. BPC-157 is not FDA approved and is sold exclusively as a research chemical. It is not intended for human consumption and is not a supplement or pharmaceutical drug.
How should BPC-157 be stored?
Lyophilized BPC-157 should be stored at -20°C for long-term stability. Once reconstituted in bacteriostatic water, it should be refrigerated at 2-8°C.
What purity should researchers look for?
Researchers should look for BPC-157 with a minimum purity of 98% as confirmed by third-party HPLC analysis. A batch-specific Certificate of Analysis should accompany every purchase.